Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009;40(3-4):115-8.
doi: 10.1007/s12029-009-9100-0.

The Relationships Between Loss of Standard CD44 Expression and Lymph Node, Liver Metastasis in T3 Colorectal Carcinoma

Affiliations

The Relationships Between Loss of Standard CD44 Expression and Lymph Node, Liver Metastasis in T3 Colorectal Carcinoma

Toshiaki Kunimura et al. J Gastrointest Cancer. 2009.

Abstract

Purpose: The aim of the present study was to evaluate the standard CD44 (CD44s) expression in colorectal cancer (CRC) with invasion to the subserosal layer (T3), its relationship with clinicopathological characteristics, and its potential metastatic significance.

Materials and methods: CD44s expression was measured on immunohistochemistry in tumors from 65 patients with primary colorectal carcinomas. CD44s expression was estimated at the deepest invaded area of the tumor in subserosal layer.

Results: CD44s was demonstrated in 35.4% (23/65). CD44s expression showed no significant relationship with the clinicopathological characteristics such as age, gender, tumor location, tumor size, and macroscopic/microscopic classification. However, the CD44s expression showed significantly adverse relationship with lymph node metastasis (p < 0.05) and liver metastasis (p < 0.01), respectively.

Conclusion: The loss of CD44s expression in cancer cells in the deepest invaded area is a good marker for predicting potential metastasis to lymph nodes and liver in T3 CRC.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Scand J Gastroenterol. 1998 Mar;33(3):301-9 - PubMed
    1. Cell. 1991 Apr 5;65(1):13-24 - PubMed
    1. Mol Pathol. 1998 Aug;51(4):191-200 - PubMed
    1. Cancer Invest. 2004;22(6):878-85 - PubMed
    1. Arch Pathol Lab Med. 2000 Feb;124(2):212-5 - PubMed

LinkOut - more resources